Non-Alcoholic Steatohepatitis (NASH) Market Strategic Imperatives for Success and Rising Demand Till 2025

The global market for Non-Alcoholic Steatohepatitis (NASH) is on a rapid growth trajectory, driven by a surge in prevalence and advancements in therapeutic options. According to recent market analysis, the NASH market was valued at $1,179 million in 2017 and is projected to reach an impressive $21,478 million by 2025, representing a remarkable Compound Annual Growth Rate (CAGR) of 58.4% from 2021 to 2025.

NASH, often referred to as a "silent liver disease," poses a significant public health challenge due to its asymptomatic nature until advanced stages, leading to underdiagnosis and increasing healthcare burden. It is anticipated to become a primary cause of liver transplantation in the United States in the foreseeable future.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐚𝐭: https://www.alliedmarketresearch.com/request-sample/224

Several key factors are propelling the expansion of the NASH market. A rising prevalence of NASH globally, coupled with the expected introduction of promising pipeline drugs, is fostering market growth. Furthermore, the substantial unmet medical needs in NASH management are creating opportunities for innovative therapies.

However, the NASH market faces challenges primarily related to diagnostic limitations. Poor diagnostic rates are attributed to the absence of ideal diagnostic technologies, hindering effective disease management and impacting market expansion.

𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐄𝐧𝐪𝐮𝐢𝐫𝐲: https://www.alliedmarketresearch.com/purchase-enquiry/224

In response to these market dynamics, stakeholders are intensifying efforts to address the unmet needs in NASH diagnosis and treatment. Healthcare providers, pharmaceutical companies, and researchers are collaborating to develop novel diagnostic tools and therapeutic interventions aimed at improving patient outcomes and reducing disease progression.

With the projected exponential growth and evolving landscape of the NASH market, there is a pressing need for continued investment in research and development, as well as strategic partnerships to accelerate innovation and expand access to effective therapies.

As we navigate this dynamic landscape, stakeholders are encouraged to prioritize patient-centered approaches, fostering greater awareness, early detection, and comprehensive management of NASH to mitigate its impact on public health.

𝐊𝐞𝐲 𝐅𝐢𝐧𝐝𝐢𝐧𝐠𝐬 𝐨𝐟 𝐭𝐡𝐞 𝐍𝐨𝐧-𝐚𝐥𝐜𝐨𝐡𝐨𝐥𝐢𝐜 𝐒𝐭𝐞𝐚𝐭𝐨𝐡𝐞𝐩𝐚𝐭𝐢𝐭𝐢𝐬 (𝐍𝐀𝐒𝐇) 𝐌𝐚𝐫𝐤𝐞𝐭:

Based on drug type, the selonsertib & cenicriviroc segment is expected to exhibit the fastest market growth, is projected to grow at a CAGR of 73.7% from 2021 to 2025.
Based on sales channel, the retail pharmacy segment held more than half of the global market share in 2017 and is expected to remain dominant throughout the forecast period.
Based on sales channel, the online provider segment exhibited fastest growth and is anticipated to grow at a CAGR of 63.2% from 2021-2025.
Based on region, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 62.62% during the forecast period.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
USA/Canada (Toll Free):
+1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-800-792-5285
help@alliedmarketresearch.com
Web:
www.alliedmarketresearch.com
Allied Market Research Blog:
https://blog.alliedmarketresearch.com
Follow Us on | Facebook | LinkedIn | YouTube |

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬 :
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.